News & Events

30th April 2020

Drug Discovery World feature article: ‘Target discovery and drug development – what comes after CRISPR?’

Benedict Cross, Chief Technology Officer, discusses the changing landscape of drug discovery, and the potential of new multi-modal screening tools such as PROTEINi, the basis for PhoreMost’s SITESEEKER® platform. For an area of research as important and impactful as drug discovery, it is surprising how often efforts are directed by short-term trends. We have seen an abundance in new tools and pl …